David Kirn, MD

Dr. David Kirn a clinician-scientist, senior biotechnology, and entrepreneur who has extensive expertise in the areas of design, clinical research, and development of oncolytic viruses, genetic therapies, and immunotherapy for cancer. He has led product design and development programs and clinical trials with over 10 biotherapeutic agents, and with over 10 different companies, leading academic programs, involving over 500 patients in Phase 1-3 clinical trials. Additionally, Dr. Kirn has founded or co-founded three companies, this experience will provide valuable knowledge during the early phases of 4D Molecular Therapeutics’ development.Dr. Kirn is the inaugural recipient of the Johnson & Johnson Innovator Award, an award, and position in the Johnson and Johnson Innovation Center program to support successful entrepreneurs with groundbreaking ideas in therapeutic areas of interest to J&J.